Cargando…

Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis

OBJECTIVE: Antibodies against leucine-rich glioma-inactivated 1 (LGI1-Abs) characterize a limbic encephalitis (LE) strongly associated with HLA-DRB1*07:01, although some patients lack LGI1-Abs in CSF or do not carry this allele. Whether they represent a different subtype of disease or have different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñiz-Castrillo, Sergio, Haesebaert, Julie, Thomas, Laure, Vogrig, Alberto, Pinto, Anne-Laurie, Picard, Géraldine, Blanc, Charlotte, Do, Le-Duy, Joubert, Bastien, Berzero, Giulia, Psimaras, Dimitri, Alentorn, Agusti, Rogemond, Véronique, Dubois, Valérie, Ambati, Aditya, Tamouza, Ryad, Mignot, Emmanuel, Honnorat, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938443/ https://www.ncbi.nlm.nih.gov/pubmed/33848259 http://dx.doi.org/10.1212/NXI.0000000000000974

Ejemplares similares

Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France
por: Hébert, Julien, et al.
Publicado: (2020)

Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis
por: Benoit, Jeanne, et al.
Publicado: (2022)

Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies
por: Simard, Claire, et al.
Publicado: (2020)

Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features
por: Peter, Elise, et al.
Publicado: (2022)

Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes
por: Déchelotte, Benoît, et al.
Publicado: (2020)

Anti-LGI1 Encephalitis With Co-occurring IgLON5 Antibodies: Clinical Features and Human Leukocyte Antigen Haplotypes
por: Schiff, Pierre, et al.
Publicado: (2023)

Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2020)

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2019)

Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review
por: Alentorn, Agustí, et al.
Publicado: (2023)

Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2022)

Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis
por: Villagrán-García, Macarena, et al.
Publicado: (2023)

Gut microbiome alterations in anti‐NMDA receptor encephalitis: caveats for result interpretation
por: Berzero, Giulia, et al.
Publicado: (2019)

Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis
por: Peris Sempere, Vicente, et al.
Publicado: (2022)

Associations between HLA and autoimmune neurological diseases with autoantibodies
por: Muñiz-Castrillo, Sergio, et al.
Publicado: (2020)

Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
por: Farina, Antonio, et al.
Publicado: (2022)

Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2023)

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis
por: Joubert, Bastien, et al.
Publicado: (2017)

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies
por: Vialatte de Pémille, Clément, et al.
Publicado: (2018)

Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases
por: Do, Le-Duy, et al.
Publicado: (2021)

Neurological Syndromes Associated with Anti-GAD Antibodies
por: Dade, Maëlle, et al.
Publicado: (2020)

Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations
por: Vogrig, Alberto, et al.
Publicado: (2023)

Multiplex family with GAD65-Abs neurologic syndromes
por: Belbezier, Aude, et al.
Publicado: (2017)

Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA)
por: Manto, Mario, et al.
Publicado: (2023)

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies
por: Berzero, Giulia, et al.
Publicado: (2018)

Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies
por: Dade, Maëlle, et al.
Publicado: (2021)

Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis
por: Chefdeville, Aude, et al.
Publicado: (2019)

Human Autoantibodies Against N-Methyl-D-Aspartate Receptor Modestly Alter Dopamine D1 Receptor Surface Dynamics
por: Gréa, Hélène, et al.
Publicado: (2019)

Neuroleptic intolerance in patients with anti-NMDAR encephalitis
por: Lejuste, Florian, et al.
Publicado: (2016)

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
por: Graus, Francesc, et al.
Publicado: (2021)

Dysregulation of the hippocampal neuronal network by LGI1 auto-antibodies
por: Fels, Elodie, et al.
Publicado: (2022)

Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo–Associated Paraneoplastic Cerebellar Degeneration
por: Peter, Elise, et al.
Publicado: (2022)

Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis
por: Vogrig, Alberto, et al.
Publicado: (2021)

The immunogenetic impact of European colonization in the Americas
por: Collen, Evelyn Jane, et al.
Publicado: (2022)

A bipolar disorder patient becoming asymptomatic after adjunctive anti-filiarasis treatment: a case report
por: Hamdani, Nora, et al.
Publicado: (2013)

Immunogenetics special issue 2023: Immunogenetics of infectious disease
por: Norman, Paul J.
Publicado: (2023)

BASIC IMMUNOGENETICS
Publicado: (1973)

Journal of Immunogenetics
por: Harris, R.
Publicado: (1974)

Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies
por: Moritz, Christian P., et al.
Publicado: (2022)

Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
por: Farina, Antonio, et al.
Publicado: (2023)

LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11
por: Sagane, Koji, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_392ou39mu8v7sg935jiod5659p